Archives December 2024

6th December 2024: The Organic World (TOW), India’s No.1 Responsible Retailer and part of the Bengaluru-based Nimida Group, is targeting the addition of 30 new stores in Hyderabad, by the end of 2025. In September this year, TOW marked its foray out of Karnataka with the launch of its first store in Hyderabad in Pragathi Nagar. This targeted expansion marks a pivotal step in TOW’s strategic growth as it aims to increase its footprint across South India.

This move underscores TOW’s commitment to making worry-free, wholesome, curated groceries accessible to a wider audience and supporting its ambitious pan-India target of INR 100 crore in revenue by the end of FY 2025. Hyderabad has been a key focus area for the brand, given the growing preference for organic and chemical-free products among consumers in the city.

TOW’s presence in the city will be marked by its ongoing investment in new store setups and comprehensive marketing efforts, alongside a 2-hour delivery service to cater to the growing demand for convenience and quick commerce. Currently, TOW has three stores in Hyderabad – in Pragathi Nagar, Kompally, and Kokapet. The expansion plan comes on the back of an overwhelming response that the brand received from consumers, across their stores and online channels.

“Our Hyderabad expansion is just the beginning of our journey to provide chemical-free, worry-free living to more people across India,” said Gaurav Manchanda, Founder, Nimida Group, the parent company of The Organic World. “We have had a great response from Hyderabad with our initial few stores. We see Hyderabad as a market that has consistently focused on building an ecosystem for chemical-free living and consumers here are far more informed and responsible in their decisions. Our aim is to empower these consumers with access to healthier and safer choices – our range of worry-free, wholesome, curated groceries – that can benefit both their well-being and the environment,” adds Manchanda

The expansion in Hyderabad is part of TOW’s broader plans to strengthen its presence in major urban centres and tier 2 and tier 3 cities across India, including Bangalore, Mysore, Chennai and Coimbatore.The expansion will include a mix of company-owned (COCO) and franchise-operated (FOFO) stores strategically located in key catchment areas. TOW intends to establish itself as a household name synonymous with worry-free, wholesome, curated groceries.

Since its inception in 2017, TOW has been dedicated to raising awareness about the importance of choosing products free of harmful chemicals. The brand’s curated range includes organic-certified, pesticide-free fruits and vegetables, chemical-free staples, hormone- and antibiotic-free dairy, personal care products free from parabens and sulfates, toxin-free homecare, as well as nutritious snacks and wellness items. Each product is carefully sourced and vetted, to meet higher than established industry standards, supporting the community’s health and environmental sustainability.

With the launch of its Hyderabad stores, The Organic World invites local residents to discover a new shopping experience dedicated to holistic living and healthier choices. As TOW continues to expand, the brand is poised to be a transformative force in the organic retail sector, helping communities embrace a cleaner, more mindful way of life.

December 5, 2024 – Hyatt India today unveiled its innovative Food and Beverage (F&B) campaign in India, poised to reinforce its position as a leader in the country’s luxury culinary landscape. The campaign aligns with Hyatt’s core value of caring for people, empowering them to be their best. With this campaign Hyatt reinforces its position as a culinary leader and further cements its reputation as a trailblazer in India’s hospitality industry.

Hyatt’s culinary journey in India is rooted in the success of its signature restaurants, including La Piazza, TK’s Oriental Grills, China House, The Flying Elephant, Malabar Café, Koyo Koyo to name a few. These iconic outlets have consistently delivered exceptional dining experiences, reflecting the brands passion for innovation, quality, creativity, and authenticity. The campaign celebrates this legacy with a bold narrative.

“This campaign represents a bold new chapter in our culinary journey, one that celebrates the evolving tastes and preferences of Indian consumers. By showcasing our commitment to exceptional cuisine, authentic service, and unforgettable experiences, we’re challenging traditional notions of luxury dining and inviting guests to discover a world of experiences that’s both accessible and exceptional. Above all, the campaign is rooted in our purpose of `Care`. The line `No matter what we do, Our restaurants take all your attention` is based on the insight that exceptional F&B experiences are a powerful thing. They can even make you forget other great things about our hotel –like fabulous service, attention to detail, the thoughtfulness. The film ends with the message `Made with Love, Cherished Forever` epitomising the attention to detail and effort behind all our F&B offerings that result in unforgettable experiences for our guests” said Deepa Krishnan, Head of Marketing, India and Southwest Asia, Hyatt.

“Hyatt globally and in ASPAC is known for our F&B programme. In India, Hyatt has a strong legacy with restaurants like La Piazza, TK’s Oriental Grills, China House, The Flying Elephant, Koyo Koyo, Malabar Café and many more. At Hyatt, we’re committed to redefining luxury dining in India. We’re passionate about exceeding expectations and crafting experiences that linger long after the meal is finished. From the first bite to the last, every detail – our chefs’ creativity, our staff’s warmth, and the ambience – is thoughtfully designed to make our guests feel truly special and celebrated,” said Thomas Angerer, Director of Food & Beverage, India and Southwest Asia, Hyatt.

Conceptualised by Animal and Directed by Achowe, the campaign can be seen across Digital, OOH and Property platforms.

The campaign takes center stage in a captivating brand film, where the exceptional gastronomic experience at Hyatt’s restaurants shines. At the heart of the film is Hareesh, a Hyatt staff member who exemplifies the brand’s commitment to exceptional service and meticulous attention to detail. Not to be outdone, the restaurant experience is equally captivating with an array of chefs who create an unforgettable experience for the guests. As the narrative unfolds, one phrase perfectly captures the essence of the Hyatt experience: “Made with Love, Cherished Forever”

“There are over 535 million posts under food on Instagram – delicious-looking reels, carousels, stories that can make your mouth water and also, fill you up. So when we set out to do a campaign about the legendary food and restaurants of Hyatt, one thing all of us were clear on was that we couldn’t lead with food – because it’s everywhere. So we started thinking about how great food makes us feel. What it makes us do. What it opens our eyes to. And finally: what great food makes us turn a blind eye to.

A thought that hopefully does justice not only to the incredible food at Hyatt but also to the fabulous, courteous, hard-working people who work there.” said Sayantan Choudhury, Senior Partner, Animal

December 5, 2024 – RingCentral, Inc. (NYSE: RNG), a global leader in AI-powered trusted business communications for companies of all sizes, today announced the opening of its new state-of-the-art office in Bangalore. This investment underscores RingCentral’s commitment to India as a pivotal center for innovation, facilitating business collaboration and reinforcing the company’s rapid growth trajectory in the region. The new office unveiling follows RingCentral recently obtaining approval of a PAN-India license from the Department of Telecommunications (DoT), authorizing service delivery across all 22 telecom circles in the country.

“India is a critical market for RingCentral, and our opening of this new office is a testament to our strong belief in the incredible talent and innovation that thrives in India,” said Kira Makagon, Chief Innovation Officer & CMO at RingCentral. “This expansion not only strengthens our presence in a key strategic region, but also fuels our mission to drive groundbreaking innovative solutions in global business communications.”

Located in a prime location next to the Swami Vivekanand Road metro station, with convenient access to Indiranagar’s vibrant social scene, restaurants, and shopping, the new facility is designed to accommodate 700+ employees. With numerous collaboration spaces, wellness rooms, and an in-house cafeteria, the office provides a world-class work environment focused on employee engagement and well-being.

“Our local presence, combined with our AI-driven cloud communications and contact center solutions, positions us to be a true partner for Indian businesses seeking to elevate their internal employee collaboration and drive superior customer experiences,” said Sathesh Murthy, MD & Engineering Head, RingCentral. “We are incredibly excited to expand our presence in Bangalore and contribute to the growth of the local tech community.”

RingCentral’s investment in India extends beyond infrastructure. The company is actively expanding its R&D efforts in areas such as AI, Business Collaboration, Contact Center solutions, and next-generation communication technologies catering to global customer needs, further solidifying its commitment to the Indian market. The company is also scaling its customer support, service engineering, and site reliability engineering (SRE) teams to ensure exceptional service for its growing customer base in the region.

6th December – In the 30th year of football’s most loved franchise, adidas announces the release of ‘Under The Tongue’ – a feature-length documentary exploring the seismic impact the boot franchise has had on the beautiful game, on and off the pitch. Officially premiering on December 5th, today sees the release of the official trailer.

Produced in collaboration with SoccerBible, the hour-long documentary features the era-defining footballers that made Predator so iconic in its early years – including David Beckham, Zinedine Zidane, and Eniola Aluko – as well as current stars such as Jude Bellingham, Alessia Russo, Aitana Bonmatí and Trent Alexander-Arnold, who reflect on early memories and what it means to be part of the Predator family.

‘Under The Tongue’ examines how a unique blend of industry-leading innovation, culture-defining design, unrivalled star power and timing all combined to create a boot that would fundamentally change the trajectory of the football boot industry and have a transformative impact on adidas as a business.

Transporting viewers back to the very origins of Predator, Craig Johnston – the man behind the initial idea of using rubber to create the now iconic Predator teeth on the boot’s upper – recounts the journey from his initial brainwave while coaching children’s football in Australia, through to finally seeing the boots on the feet of the world’s best players in 1994, before exploring the silhouette’s undeniable impact in the following 30 years.

The documentary also sees senior adidas executives, design team members and notable fans – including singer-songwriter and football fanatic Louis Tomlinson – recall their own experiences of Predator’s emergence.

Nick Craggs, adidas Global Football General Manager said: “Predator changed the game. We know what it means to us all at adidas but as we come to the end of its 30th anniversary we felt it was fitting to hear from those that played such a crucial role in cementing its place in football culture. It has helped push the boundaries of innovation on the field of play and inspire millions off it – we now take it into the future and hopefully another 30 years of iconic moments with the world’s best players.”

Pete Martin, Creative Director at SoccerBible said: “The Predator is a boot with such a profound legacy that it was a real honor to have crafted ‘Under The Tongue’ alongside Keane Pearce Shaw. A boot with such personality too, not only does it mean so much to the culture of the game but it has been an unrivaled yet consistent giver of glory. There are few products on the planet that can, have or ever will, evoke such memories and feeling than that of the Predator. It’s almost immortal. That’s what we have tried to capture with this film – that powerful infatuation – a charming icon with bite, flair and beauty.”

December6, 2024 – The Integrated Health & Wellbeing (IHW) Council will host the Lung Health & Oncology National Conference 2024 on December 7, 2024, at the Ambedkar International Convention Centre, New Delhi. It will be a distinguished gathering of influential national stakeholders from governmental agencies, health sectors, and other allied organizations to discuss major issues in lung cancer management and make headway on personalized health care in the country.

Lung cancer happens to be the fourth most common cancer in India, with an annual incidence of 72,510 cases and 66,279 deaths, as calculated by The Lancet. Contributing factors include growing air pollution, industrial exposure, and smoking. Key areas of discussion at this conference will be patient-centric care, precision medicine, and cutting-edge diagnostic developments that characterize the future of oncology. It aims to foster cooperation and exchange of knowledge as well as elevate standards in treating lung cancer, focusing on innovation, early detection, and equal access to advanced care.

The event will feature an esteemed line-up of speakers, including Mr. Kamal Narayan, CEO, IHW Council; Dr. Saroj Das Majumder, Professor & HOD, Radiation Oncology Department, AIIMS, Bhubaneshwar; Col Rajeev Mannali, CEO, SUT Pattom Super Speciality Hospital; Mohammed Yahya, Director – CEO’s Office at Qure.ai; Dr. Charu Bahl, Senior Manager: Scientific Affairs Manager at Medgenome Labs; Dr.Moushumi Suryavanshi, Senior Consultant & Head (Molecular biology and cytogenetics); Dr. Anant Mohan, AIIMS Delhi; Col (Dr.) Shafin Babu, Associate Professor and Consultant Pulmonologist Department of Pulmonary- Critical Care and sleep Medicine, Command Hospital Eastern Command, Kolkata; Dr. Sridhar P S, Radiation Oncologist; Dr. Belal Bin Asaf, Founder Trustee, Associate Director of the Institute of Chest Surgery, Chest Onco-Surgery & Lung Transplantation at the Medanta – The Medicity, Gurugram, Haryana; Dr. Aditya Murali, Senior Consultant, Medical Oncology and Hemato Oncology, Apollo Hospitals; Dr. Subodh Kumar, Professor AIIMS, Deoghar; Dr. Navneet Singh, Professor, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education & Research (PGIMER); Vandana Mahajan, Lead Counsellor, Lung Connect; Mr. Vivek Tomar, (PhD, MPharm, Certification in NGO organisation management), Co-founder – “Rise To Survive Cancer; Dr. Urvashi Prasad, Former Director Niti Aayog.

The conference agenda is designed to facilitate insightful discussions on important issues. Sessions will be presented exploring the epidemiology of lung cancer in India, the impact of public awareness and the importance of screening and improving infrastructures to reduce the disease burden. The role of AI technology will also be discussed, as well as how it is transforming the detection of lung cancer, allowing early detection and accurate diagnostic capabilities, especially in resource-deprived settings. The focus will also be on molecular biomarkers, which can offer important insights into tumor biology to enable timely and personal interventions.

A session on multidisciplinary treatment approaches will discuss new advances in the management of Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). Experts would be discussing the practical applicability of global guidelines, innovative treatments, and the challenges these bring in their implementation into the Indian scenario. The end will culminate in a session to address lacunas in lung cancer care and explore regional disparities as well as actionable solutions like the role patient advocacy groups play in bettering equitable healthcare access.

Kamal Narayan Omer, Founder and CEO of IHW Council, emphasized the significance of the event, stating, “One of the most serious health issues confronting the country today is lung cancer. This is an issue that needs immediate and collective attention from all stakeholders involved. This conference provides a great opportunity for experts, innovators, and policymakers under one roof to discuss innovative solutions for the care of lung cancer. By focusing on new diagnostic technologies, early detection approaches, and equitable access to personalized treatments, we can create a way for better outcomes and a stronger healthcare ecosystem. We must make meaningful progress and offer renewed hope to patients and families suffering from this challenging disease.”

The Lung Health & Oncology National Conference 2024 is, therefore a much-needed step for the conquest of lung cancer in India. It lays emphasis on prevention, early detection, and advanced treatment approaches, facilitating collaboration and innovation for effective change in the management of lung cancer.

6 December, 2024, Bengaluru: A specialized research program on systemic caste-based inequalities in organizations and societies comprising of an international team of scholars that includes IIMB Strategy area faculty Prof. Prateek Raj, won the 2024 Australian Business Deans Council Network Award for Established, Scholarly Research.

The research program, comprising 20+ scholars across Australia, the UK, and India, has set a benchmark by integrating ethical considerations of caste into management discourse.

The program deployed three distinct approaches—theory development, empirical testing, and community building—and leveraged its analysis of organizational human capital data to design targeted interventions that address pressing social challenges. With community-building, an original impetus of the initiative has also been to advance and enrich comprehensive, interdisciplinary, empirical areas of enquiry. In addition, it has also supported the development of early-career, female, and underrepresented academics around the world.

Having influenced both scholarship and policy, the findings have led to policy adoption by the Melbourne City Council and the Australian Human Rights Commission. Outcomes also include 16 articles published in top-tier journals, media pieces, and presentations to community stakeholders.

Among these papers is a PLOS One paper, co-authored by Prof. Prateek Raj, Prof. Hari Bapuji, University of Melbourne, and Thomas Roulet, University of Cambridge, titled, ‘It’s not who you know, but who you are: Explaining income gaps of stigmatized-caste business owners in India’. The study, which examines the income gap faced by Dalit business owners, was hailed as a “significant contribution to the discourse on economic inequality” this year by The Hindu.

Prof. Raj, who founded the Inclusive Markets Lab at IIMB, is also the Co-founder of ‘Action to Improve Representation’, an initiative that aims to improve representation and open doors for underrepresented South Asian scholars in management academia.

Cardiovascular disease (CVD) remains a leading cause of death in Australia, with diet-related factors such as high blood pressure, elevated body mass index, and high cholesterol levels significantly contributing to its prevalence. Emerging research highlights almonds as a nutritional powerhouse that can play a vital role in promoting heart health.
Almonds and Heart Health
With over 25 years of scientific research, almonds are celebrated for their heart-protective benefits. A systematic review in 2016 demonstrated that diets enriched with almonds significantly reduced total cholesterol, LDL (“bad”) cholesterol, and triglycerides, without affecting HDL (“good”) cholesterol levels. Australian almonds contain healthy fats, known as monounsaturated fats which are good for the heart. These monounsaturated fats help to lower ‘bad’ cholesterol and total cholesterol, reducing the risk of heart disease. But it’s not just the good fats, it’s the unique nutrient matrix that Australian almonds contain that supports heart health, including plant protein, fibre, calcium, vitamin E, phytosterols, polyphenols and many other vitamins and minerals.
Why Almonds? Almonds stand out for their unique nutrient matrix, which combines:
● Healthy Fats: Low in saturated fat and high in mono- and polyunsaturated fats.
● Fibre & Phytosterols: Contributing to reduced cholesterol reabsorption and increased excretion.
● Antioxidants: Helping to combat oxidative stress linked to cardiovascular damage.
● L-arginine: Supporting endothelial function by improving nitric oxide bioavailability.
Almonds in Everyday Diets
The Australian Dietary Guidelines recommend consuming 30 grams of nuts, including almonds, daily. Incorporating almonds as a portable and convenient snack, or as part of recipes inspired by the Mediterranean diet, has shown promise in reducing CVD risk by up to 30%.
What Does the Research Say?
Reducing Oxidative Stress: Regular almond consumption is associated with reduced oxidative stress—a condition contributing to the onset of diseases like diabetes and CVD.Improving Endothelial Function:Studies indicate that nuts, rich in L-arginine, can enhance blood vessel function, reducing risks linked to atherosclerosis. Mediterranean Diet Benefits: The landmark PREDIMED study demonstrated that older adults on a Mediterranean diet supplemented with nuts experienced a 30% reduction in CVD incidence.

5th December, 2024: Redcliffe Labs, a purpose-driven pan-India omnichannel diagnostics service provider, has conducted a study that reveals arthritis is no longer limited to older adults. It affects individuals of all age groups and genders. Conducted over three years with 2 million tests, it revealed that approximately 1 in 5 people are at risk of developing arthritis.

Arthritis symptoms often worsen during the winter season. Colder temperatures can increase joint stiffness and inflammation, making timely intervention even more critical. Individuals with arthritis are advised to adopt preventive measures such as regular physical activity and joint care. With India witnessing a remarkable rise in preventive healthcare awareness, the number of individuals seeking regular health checkups increasing by over threefold from 2022 to 2024. This growing focus on early detection is a critical step toward better health outcomes for millions. With a focus on increasing awareness about the health issue, Redcliffe Labs’ study highlights the gender-neutral nature of arthritis.

The study found abnormal test results in 18% of men and 10% of women aged 26 to 40. It indicates that arthritis is not exclusive to women; instead, the onset of arthritis is higher in men at a younger age, whereas the abnormalities are higher in women with increasing age. Both men and women should be equally cautious and proactive about their health, particularly during colder months.

Dr. Geetanjali Gupta, Director of Technical Operations and Quality Assurance at Redcliffe Labs, stated, “We are observing a shift in the demographics affected by arthritis. With 1 in 5 people at risk of developing arthritis, especially in the younger age group, early diagnosis becomes crucial in preserving mobility and quality of life. Identifying the condition in its early stages allows for proactive treatment, lifestyle adjustments, and long-term management that can significantly slow its progression and reduce its impact. It is crucial to raise awareness and encourage preventive measures to address this growing health concern.”

Furthermore, the study highlights that women, especially as they age, face a higher risk of developing arthritis. The risk increases from 10% in the age group above 25 to 33% in the age group above 70. However, the risk of developing arthritis remains relatively consistent for men of all ages.

The findings emphasize the importance of early diagnosis, particularly for younger adults, to enhance the quality of life.

Aditya Kandoi, CEO and founder of Redcliffe Labs, also commented on the findings, stating, “The growing awareness of preventive health checkups is encouraging, but there is still much to be done in combatting chronic autoimmune conditions like arthritis. At Redcliffe Labs, we are dedicated to not only providing affordable and accessible diagnostics but also promoting a cultural shift towards proactive health management. Prevention is the future of healthcare, and we are committed to ensuring that more people can take control of their health before it’s too late.”

As arthritis cases increase and more people become aware of the importance of regular checkups, Redcliffe Labs continues to emphasize the significance of preventive care in addressing the country’s growing health challenges.

5 December 2024: Doctors at Fortis Hospital Noida have successfully performed a complex and high-risk surgery to remove a renal tumour in a 59-year-old woman suffering from Multiple vascular anomalies – a congenital condition where a person has multiple abnormal blood vessel supplying the kidneys. It is a rare condition and occurs in 1 in 25,000 cases.

In normal cases, a kidney has one artery, one vein and one ureter, but in this particular case, the patient was born with 4 renal arteries and 2 ureters. Extracting the tumour from the lower part of her left kidney by clamping multiple veins and arteries was a difficult task. However, the team of doctors led by Dr Piyush Varshney – Director, Urology & Kidney Transplant, Fortis Hospital, Noida conducted the high-risk procedure with the help of Robotic Partial Nephrectomy in mere 90 minutes and the patient was discharged in a stable condition.

The patient was admitted to Fortis Noida with severe pain on the left side of her body, extending from the bottom of the rib cage to the hips. An ultrasound was done, which revealed a tumour on the lower part of her left kidney. Additionally, a CT Urography was also conducted, which revealed multiple abnormal blood vessel. Due to this condition, it was difficult to dissect the blood vessels, tie them separately and cut the tumor, without blood loss. To address the complexity of the case, the team opted for a robot-assisted partial nephrectomy, which provided a 10 times magnified view of the blood vessels and allowed for meticulous dissection and tumour removal.

Giving details of the case, Dr Piyush Varshney – Director, Urology & Kidney Transplant, Fortis Hospital, Noida said, “The surgery was challenging due to the complexity of identifying all the major vessels supplying blood to the kidney, dissecting them without causing injury, and clamping each and every artery and veins separately to remove the kidney tumour without blood loss. However, with the help of Robot-assisted partial nephrectomy, we could successfully remove the tumour without damaging any surrounding tissues or blood vessels. If the tumour was not removed on time, it could have ruptured any time leading to severe bleeding. The problem with such a tumour is that they are composed of fat and blood vessels and has no protective covering. Therefore, a small injury can lead to rupture and the patient may bleed profusely, leading to sudden fall of blood pressure.”

Mohit Singh, Zonal Director, Fortis Hospital, Noida said, “It was a challenging case and, in such cases, it is very important to consult a multi-specialty hospital which is well equipped with the best medical facilities. We have a comprehensive robot-aided surgical program at Fortis Noida, with the specialized team of doctors.”

5Th Nov 24– Neuranics, a healthcare diagnostics startup, has successfully raised 700K USD funding in a seed round led by Inflection Point Ventures (IPV). The funds will be utilized for technology development and clinical validation, enabling the company to accelerate its mission to revolutionize blood diagnostics.

Neuranics is developing a point-of-care blood analyzer capable of delivering complete blood count (CBC) results in less than 10 minutes using just a finger-prick sample. The device, designed for primary and emergency settings, offers low maintenance and high efficiency, making it a game-changer for the healthcare industry.
Having accurate CBC results available immediately at the point of care, while the physician is still with the patient, allows for better-informed decisions regarding triage, additional testing, and treatment as delays are no longer caused by transport and preparation of clinical samples.This approach benefits not only the patient, who experiences improved outcomes, but also the physician, who can diagnose, triage, and treat with greater confidence. Society also reaps the rewards through reduced healthcare costs and enhanced quality care. Unnecessary, costly, and potentially harmful medications, such as inappropriate antibiotics, can be avoided. At the same time, life-saving treatments for critical conditions like sepsis, severe anemia, and thrombocytopenia, especially in dengue patients, can be initiated promptly, ensuring timely and effective care.

With their compact dry haematology design and efficiency in delivering results directly at the point of care, Neuranics is ideally suited to address this need effectively.

Founded in 2021 by Praveen Kumar (Co-founder & CEO) and Ashutosh Patra (Co-founder & CTO), Neuranics addresses critical gaps in diagnostics, particularly in primary screening. Praveen, an IIT Delhi graduate, brings extensive experience in healthcare technology, having previously worked with the government on projects like Corona Kavach and Aarogya Setu. Ashutosh, an alumnus of the SiB(Previously Stanford India Biodesign) Program at AIIMS, leads product innovation at Neuranics with expertise in optical sensing technologies and mechanical engineering.

Mitesh Shah, Co-founder of IPV, says, “Neuranics is tackling the problem of lengthy and complex blood testing processes with their point-of-care blood analyzer that makes complete blood count diagnosis faster and easier. This significantly improves patient care, especially in urgent cases. IPV believes in the startups innovative technology and envisions a future where the startups bring out more such necessary tools”.

Dr Megha Sharma, MD Pathologist and Chief Medical Evangelist at Neuranics says, “Our point-of-care CBC analyzer represents a significant leap forward in diagnostic convenience and accessibility. By utilizing a simple finger-prick capillary blood sample. We have effectively eliminated the need for traditional venipuncture, making blood testing faster, less invasive, and more patient-friendly. This technology empowers healthcare providers to deliver immediate, actionable insights, even in resource-limited settings, ultimately improving patient outcomes especially in Primary health care centres for screening and at emergency setups for triage. ”

The company has achieved significant milestones, including a patent granted, receiving the CDSCO Test License, Ethical Approval from AIIMS Delhi, and progressing through clinical trials. Neuranics also gained recognition at Yourstory Tech30, Amazon-Sambhav and India-Sweden Innovation Challenge for its potential to decentralize routine diagnostics, offering quicker and more accessible screening for conditions such as anemia, thalassemia, malaria, and leukemia.

Praveen Kumar, Co-founder & CEO of Neuranics, says, “We are re-imagining how we approach diagnostics by bringing instant, accurate blood analysis closer to the patient without compromising on the quality. Our technology empowers clinicians with real-time data, transforming care delivery and elevating patient outcomes.

By leveraging AI on de-identified pathological imaging data generated by our analyzer, we aim to set a new gold standard for national screening programs. This innovative technology will elevate healthcare quality in India and establish the country as a global leader in point of care blood analyser.

We thank IPV for being with us in this journey. Working with IPV has been a streamlined and transformative experience. Their investment and guidance have empowered us to scale faster, innovate further, and bring our vision to life. IPV’s efficient processes and industry connections have been instrumental in our journey.”

Neuranics operates in the fast-growing diagnostics industry, with the global CBC market projected to reach $50 billion, expanding at a CAGR of 8-10%. The company’s focus and expertise in precision robotics, machine vision, and microfluidics positions it as a leader in the next generation of diagnostic technologies.